Analysts at Berenberg Bank assumed coverage on shares of Craneware (LON:CRW – Get Free Report) in a research report issued on Wednesday, MarketBeat reports. The brokerage set a “buy” rating and a GBX 2,800 ($37.60) price target on the stock. Berenberg Bank’s price objective would indicate a potential upside of 12.90% from the stock’s previous close.
Separately, Shore Capital reaffirmed a “buy” rating on shares of Craneware in a research report on Thursday, May 8th.
Get Our Latest Report on Craneware
Craneware Stock Performance
Insider Activity at Craneware
In other news, insider Will Whitehorn acquired 1,911 shares of Craneware stock in a transaction dated Thursday, April 24th. The stock was purchased at an average cost of GBX 1,584 ($21.27) per share, for a total transaction of £30,270.24 ($40,647.56). Insiders own 19.28% of the company’s stock.
About Craneware
The Craneware Group, the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group’s Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care.
Recommended Stories
- Five stocks we like better than Craneware
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- The Market Rally Is Gaining Momentum—Don’t Get Left Behind
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- High-Flying GE Aerospace Drops After Blowout Q2 — What Now?
- Manufacturing Stocks Investing
- Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate
Receive News & Ratings for Craneware Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Craneware and related companies with MarketBeat.com's FREE daily email newsletter.